王文芳, zheng cai hua, Tan Hong Hua. Research Progress on Traditional Chinese Medicine Treatment of Ulcerative Colitis. 2026. biomedRxiv.202605.00009
Research Progress on Traditional Chinese Medicine Treatment of Ulcerative Colitis
Corresponding author: zheng cai hua, 3227305591@qq.com
DOI: 10.12201/bmr.202605.00009
-
Abstract: Abstract:Ulcerative colitis (UC) is a stubborn intestinal inflammatory disease with an unclear pathogenesis, characterized by clinical manifestations such as abdominal pain, diarrhea, recurrent mucus and bloody stools, and tenesmus. Epidemiological data show that the incidence of this disease is continuously rising, and the peak age group of onset is showing a trend of younger age, which has seriously threatened the quality of life of patients. Mesalazine is a basic drug for the treatment of ulcerative colitis, and its treatment mainly focuses on the intestinal mucosa, belonging to an anti-inflammatory drug with local intestinal action. However, this treatment method has limitations. Even if the intestinal inflammation of UC patients is relieved, they still have long-term symptoms such as abdominal pain and diarrhea, and the immune function of the body has not been fundamentally improved, leading to an easy recurrence of the disease. The treatment goal of UC is to effectively control and continuously relieve clinical symptoms, promote the repair and regeneration of damaged intestinal mucosa, and prevent complications. This article summarizes the research content of traditional Chinese medicine on UC to further promote the application research of traditional Chinese medicine in the clinical treatment of UC.
Key words: Ulcerative colitis; Traditional Chinese Medicine; Spleen deficiencySubmit time: 2 May 2026
Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity. -
图表
-
Ling Ping, Ye Lu, Liu Yongpan, Ni Siyi, Shen Yan. Exploring the dynamic evolution character istics of ulcerative colitis pathogenesis based on “Damp-phlegm-blood stasis-deficiency-poison”. 2024. doi: 10.12201/bmr.202409.00040
Xia Qi, Wang Zhenquan. Famous Doctors Experience in Treating Ulcerative Colitis Based on the Theory of Zhuang Huo Shi Qi. 2025. doi: 10.12201/bmr.202510.00006
SU Shasha. Research progress on the correlation between CAR, NAR, PAR, CRP/IBIL and the activity of ulcerative colitis. 2026. doi: 10.12201/bmr.202601.00094
duanpeiyao, dingkang, tanyanyan. Prevention and Treatment of Ulcerative Colitis with the Intestinal Mucosal Barrier As Target Based on Theory of “Spleen Being the Defensive Organ of Zang-Fu Viscera”. 2025. doi: 10.12201/bmr.202512.00009
YU Yunfeng, YANG Xinyu, HU Gang, Tang Xudong, YOU Yunge. Based on the Theory of Yin and Yang to Explore the Mechanism of Autophagy in Ulcerative Colitis and Chinese Medicine Intervention Strategies. 2025. doi: 10.12201/bmr.202501.00001
Ding Kang. . 2025. doi: 10.12201/bmr.202511.00081
Li jie. Research Progress on the Treatment of Carotid Atherosclerotic Plaques with Traditional Chinese Medicine. 2025. doi: 10.12201/bmr.202512.00072
ZHANG Yi, Yuan Ping. Progress of research on the treatment of tobacco dependence by external therapeutic methods of traditional Chinese medicine. 2024. doi: 10.12201/bmr.202411.00040
莲承杰, ZHOU Kuichen, Xu Canli, BA Yinying, WANG Wenjuan, CHI Li, WANG Jiajia. Research Progress on the traditional Chinese medicine Treatment of Inflammatory Diseases Based on the Cuproptosis. 2026. doi: 10.12201/bmr.202601.00064
LUOJUNJIE, LIAN YONGKANG, CHENHONG. Progress in Traditional Chinese Medicine Diagnosis and Treatment of Tic disorders in Children. 2025. doi: 10.12201/bmr.202503.00007
-
ID Submit time Number Download 1 2026-04-09 10.12201/bmr.202605.00009V1
Download -
-
Public Anonymous To author only
Get Citation
Article Metrics
- Read: 74
- Download: 3
- Comment: 0

Login
Register




京公网安备